Literature DB >> 20085510

The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis.

Chris Hemmings1.   

Abstract

The cancer stem cell hypothesis suggests that malignant tumours may arise from a limited number of specialised cells possessing the key 'stem' properties of self-renewal and the ability to produce differentiated progeny. Such cells purportedly constitute a small fraction of most tumours but have greater potential to produce new tumours than their 'non-stem' counterparts. However, they have proven difficult to identify and characterise in most malignancies. Cancer stem cells are liable to be resistant to most forms of conventional chemotherapy and radiation and so may help to explain tumour recurrence after a seemingly good response to initial therapy. This review examines the evidence for the existence of such cells, the therapeutic implications of this hypothesis, and problems posed by it, as well as outlining the concept of the stem cell niche and its possible role in tumour development and progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20085510     DOI: 10.3109/00313020903488773

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  18 in total

1.  The RP-p53-Mdm2 pathway: a new link to genetic integrity?

Authors:  Rebeca A Frum; Yanping Zhang
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

2.  TNF-α induced epithelial mesenchymal transition increases stemness properties in renal cell carcinoma cells.

Authors:  Linlin Zhang; Min Jiao; Kaijie Wu; Lei Li; Guodong Zhu; Xinyang Wang; Dalin He; Dapeng Wu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  A radiobiological model of radiotherapy response and its correlation with prognostic imaging variables.

Authors:  Mireia Crispin-Ortuzar; Jeho Jeong; Andrew N Fontanella; Joseph O Deasy
Journal:  Phys Med Biol       Date:  2017-01-31       Impact factor: 3.609

Review 4.  Interferons as inducers of apoptosis in malignant cells.

Authors:  Kevin P Kotredes; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

5.  Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo.

Authors:  Greg M Thurber; Katy S Yang; Thomas Reiner; Rainer H Kohler; Peter Sorger; Tim Mitchison; Ralph Weissleder
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells.

Authors:  Amber Wilson; Lina A Shehadeh; Hong Yu; Keith A Webster
Journal:  BMC Genomics       Date:  2010-04-07       Impact factor: 3.969

7.  The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.

Authors:  Jeho Jeong; Vicki T Taasti; Andrew Jackson; Joseph O Deasy
Journal:  Radiother Oncol       Date:  2020-09-23       Impact factor: 6.280

8.  Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response.

Authors:  J Jeong; K I Shoghi; J O Deasy
Journal:  Phys Med Biol       Date:  2013-06-21       Impact factor: 3.609

9.  Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours.

Authors:  D E White; S A Burchill
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

10.  Multi-level model for the investigation of oncoantigen-driven vaccination effect.

Authors:  Francesca Cordero; Marco Beccuti; Chiara Fornari; Stefania Lanzardo; Laura Conti; Federica Cavallo; Gianfranco Balbo; Raffaele Calogero
Journal:  BMC Bioinformatics       Date:  2013-04-17       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.